Health Care & Life Sciences » Pharmaceuticals | Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.65
Market Cap
$252.26 M
Shares Outstanding
27.1 M
Public Float
19.77 M

Profile

Address
35 Gatehouse Drive
Waltham Massachusetts 02451
United States
Employees -
Website http://www.syndax.com
Updated 07/08/2019
Syndax Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A.

Financials

View All

Briggs W. Morrison
Chief Executive Officer & Director
Keith A. Katkin
Director